[1]
B. Shah, N. Nagar, and S. S. Nagar, “A comparative study of maternal & neonatal outcome and patient satisfaction with intravaginal misoprostol versus intravenous oxytocin in patients with premature rupture of membranes beyond 36 weeks gestation”, Int J Basic Clin Pharmacol, vol. 2, no. 3, pp. 315–319, Jan. 2017.